Global Rheumatic Heart Disease Market Insights 2029: Drivers, Challenges, and Revenue Forecast
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Predicted Market Size Of The Rheumatic Heart Disease Industry By 2029?
In the recent past, the market for rheumatic heart disease has seen substantial growth. The market which stood at $2.56 billion in 2024 is expected to escalate to $2.71 billion in 2025, with a compound annual growth rate (CAGR) of 5.9%. Factors that have led to this growth over the historic period include high instances of untreated strep infections, limited availability of healthcare facilities in low-income regions, insufficient awareness about the disease, delayed diagnosis and treatment, and lack of adequate immunization initiatives.
The market for rheumatic heart disease is anticipated to witness robust growth in the upcoming years, escalating to a value of $3.42 billion by 2029, with a CAGR of 5.9%. Various factors contributing to this expected surge during the forecast period include an increase in preventive screening programs, heightened awareness for earlier detection, augmented healthcare spending in developing regions, growth of telemedicine for remote diagnostic purposes, and governmental measures towards disease control. The forecast period is also envisaged to see trends like heightened usage of AI for diagnosis, extending echocardiography-based screening, incorporation of mobile health solutions, invention of new anti-inflammatory treatments, as well as partnerships for worldwide disease elimination.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23502&type=smp
Which Industry Forces Are Driving The Rheumatic Heart Disease Market Forward?
The rise in strep throat cases is anticipated to fuel the expansion of the rheumatic heart disease market. Strep throat, a bacterial infection resulting from streptococcus pyogenes (group a streptococcus), causes inflammation and pain in the throat, usually accompanied by fever, swollen lymph nodes, and difficulty swallowing. The growing resistance to antibiotics is complicating the effective treatment of streptococcal infections, leading to longer illnesses and elevated transmission rates in communities. Rheumatic heart disease is a long-lasting complication of uncured or recurrent strep throat infections, highlighting the significance of early detection and treatment of such infections to prevent severe heart damage. For example, the Centers for Disease Control and Prevention, a US government department, reported in April 2023 that strep throat is responsible for about 5.2 million yearly outpatient visits among those under 65 years old. These visits result in 2.8 million antibiotic prescriptions per annum. Hence, the escalating prevalence of strep throat is catalyzing the growth of the rheumatic heart disease market.
What Is The Segment Breakdown Of The Rheumatic Heart Disease Market?
The rheumatic heart diseasemarket covered in this report is segmented –
1) By Type: Valve; Myocarditis; Pericarditis
2) By Age Group: Pediatric; Adolescent; Adult; Geriatric
3) By Application: Hospital; Diagnostic Centre; Research Centre
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Direct Sales
Subsegments:
1) By Valve: Mitral Valve Disease; Aortic Valve Disease; Tricuspid Valve Disease; Pulmonary Valve Disease
2) By Myocarditis: Acute Myocarditis; Chronic Myocarditis; Fulminant Myocarditis
3) By Pericarditis: Acute Pericarditis; Chronic Pericarditis; Constrictive Pericarditis; Effusive Pericarditis
What Are The Dominant Trends Currently Seen In The Rheumatic Heart Disease Market?
Leading businesses in the rheumatic heart disease market are strategically collaborating to pioneer novel diagnosis methods and treatments. These strategic alliances in the management of rheumatic heart disease (RHD) combine knowledge and tools to accelerate research & development, improve the development of diagnostic and therapeutic solutions, widen market reach, and speed up commercialization. For example, in July 2023, a non-government organization from Switzerland, the World Heart Federation (WHF), joined forces with the Philips Foundation, a Dutch nonprofit organization, to raise awareness about RHD, enhance medical training, and promote early detection in the Asia-Pacific (APAC) area. Initiated in the Philippines, this project aims to provide access to quality healthcare to more than half a million Filipino children at risk by equipping facilities with highly-skilled professionals and sophisticated diagnostic instruments. This partnership highlights a shared dedication to bolster healthcare systems and assure prompt intervention for patients suffering from RHD.
Which Companies Are Contributing Significantly To The Rheumatic Heart Disease Market Growth?
Major companies operating in the rheumatic heart disease market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis AG, Abbott Laboratories, GlaxoSmithKline plc (GSK), Medtronic plc, Siemens Healthineers AG, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company (BD), GE HealthCare Technologies Inc., Mayo Clinic, Boston Scientific Corporation, Johns Hopkins Medicine, Terumo Corporation, The Mount Sinai Health System Inc., Apollo Hospitals Enterprise Limited, Fortis Healthcare Limited, Medanta.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/rheumatic-heart-disease-global-market-report
Which Region Is Leading Innovation In The Rheumatic Heart Disease Market?
North America was the largest region in the rheumatic heart disease market in 2024. The regions covered in the rheumatic heart disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=23502&type=smp
Browse Through More Reports Similar to the Global Rheumatic Heart Disease Market 2025, By The Business Research Company
Prosthetic Heart Valve Devices And Equipment Global Market Report 2025
Hearth Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/hearth-global-market-report
Flea Tick And Heartworm Products Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
